Table 4.
Characteristics of the PTC-with-HPT group: non-remission and mortality.
| Characteristic | Non-remission (n = 3) | Mortality (n = 4) | |||||
|---|---|---|---|---|---|---|---|
| Age at diagnosis, sex | 53, F | 31, M | 54, M | 44, F | 65, F | 61, F | 63, F |
| Pathology of PTC | C | C | C | C | C | C | FV |
| Multifocality | no | yes | yes | no | no | no | no |
| Tumor size (cm), stage | 0.2, T1A | 1.0, T1A | 4.0, T4A | 2.4, T4A | 0.4, T1A | 1.5, T1B | 1.4, T1B |
| Lymph nodes status | N0 | N1A | N1A | N0 | N0 | N0 | N0 |
| TNM stage | SI | SI | SVIa | SI | SI | SI | SI |
| Total thyroidectomy | yes | yes | yes | yes | no | no | yes |
| 1M-Post-op Tg (ng/mL) | 13.8 | 512 | 63.6 | 2.95 | 64.2 | – | 13.7 |
| Post-op131I dose (mCi) | 100.0 | 420.0 | 490.0 | 29.8 | – | – | 30.0 |
| Time-to-event (year) | 0.7 | 10.8 | 6.9 | 8.5 | 4.3 | 4.2 | 4.5 |
| Location or death cause | neck, lung | neck | neck | stroke | unknown | unknown | ALI |
| Second primary cancer | no | RCC, HCC | no | no | TCC | no | no |
| Etiology of HPT | primary | renal | primary | renal | renal | renal | renal |
F, female; M, male; C, classic; FV, follicular variant; 1M-Post-op Tg, one-month postoperative serum thyroglobulin level; Post-op 131I dose, postoperative 131I cumulative dose; ALI, acute limb ischemia; RCC, renal cell carcinoma; HCC, hepatocellular carcinoma; TCC, transitional cell carcinoma.